Revolutionizing GERD diagnosis: how capsule sponge testing prioritizes high-risk patients while easing the strain on endoscopy services. Study: Clinical application of capsule sponge testing in ...

Capsule sponge-based surveillance could be used in lieu of endoscopy for low-risk Barrett esophagus (BE) surveillance, a prospective multisite UK study found. The biomarker risk panel collected by the ...

The researchers found that in the high-risk patient group, the positive predictive value for any dysplasia or worse was 37.7%. HealthDay News — In adult patients with nondysplastic Barrett esophagus ...

Please provide your email address to receive an email when new articles are posted on . A capsule-sponge test may help risk-stratify patients with Barrett’s esophagus. Patients classified as low risk ...

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett’s oesophagus, a known precursor to oesophageal cancer, according to a new study from ...

Cyted Ltd. received U.S. FDA 510(k) clearance for its Endosign capsule technology, a non-endoscopic capsule sponge device used to collect pan-esophageal samples to detect esophageal pre-cancer and ...

Patients with Barrett’s esophagus are currently monitored for signs of cancer through regular endoscopy, an invasive procedure in which a camera is passed down the esophagus into the stomach, which ...

Somerset NHS launches AI-powered oesophageal cancer screening, inviting residents via text for early capsule sponge tests at ...

MONDAY, June 30, 2025 (HealthDay News) -- In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying those at highest risk of ...